These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21102518)

  • 1. Efficient in vivo microRNA targeting of liver metastasis.
    Huynh C; Segura MF; Gaziel-Sovran A; Menendez S; Darvishian F; Chiriboga L; Levin B; Meruelo D; Osman I; Zavadil J; Marcusson EG; Hernando E
    Oncogene; 2011 Mar; 30(12):1481-8. PubMed ID: 21102518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of microRNAs in vivo with 'antagomirs'.
    Krützfeldt J; Rajewsky N; Braich R; Rajeev KG; Tuschl T; Manoharan M; Stoffel M
    Nature; 2005 Dec; 438(7068):685-9. PubMed ID: 16258535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration.
    Sarver AL; Li L; Subramanian S
    Cancer Res; 2010 Dec; 70(23):9570-80. PubMed ID: 21118966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting.
    Esau C; Davis S; Murray SF; Yu XX; Pandey SK; Pear M; Watts L; Booten SL; Graham M; McKay R; Subramaniam A; Propp S; Lollo BA; Freier S; Bennett CF; Bhanot S; Monia BP
    Cell Metab; 2006 Feb; 3(2):87-98. PubMed ID: 16459310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metastasis-associated microRNA miR-516a-3p is a novel therapeutic target for inhibiting peritoneal dissemination of human scirrhous gastric cancer.
    Takei Y; Takigahira M; Mihara K; Tarumi Y; Yanagihara K
    Cancer Res; 2011 Feb; 71(4):1442-53. PubMed ID: 21169410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-106a-mediated malignant transformation of cells induced by anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide.
    Jiang Y; Wu Y; Greenlee AR; Wu J; Han Z; Li X; Zhao Y
    Toxicol Sci; 2011 Jan; 119(1):50-60. PubMed ID: 20889678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of microRNA expression in vinyl carbamate-induced mouse lung tumors and modulation by the chemopreventive agent indole-3-carbinol.
    Melkamu T; Zhang X; Tan J; Zeng Y; Kassie F
    Carcinogenesis; 2010 Feb; 31(2):252-8. PubMed ID: 19748927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging Dendrimer-Grafted Graphene Oxide Mediated Anti-miR-21 Delivery With an Activatable Luciferase Reporter.
    Wang F; Zhang B; Zhou L; Shi Y; Li Z; Xia Y; Tian J
    ACS Appl Mater Interfaces; 2016 Apr; 8(14):9014-21. PubMed ID: 27010367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA expression profiles in human colorectal cancers with liver metastases.
    Lin M; Chen W; Huang J; Gao H; Ye Y; Song Z; Shen X
    Oncol Rep; 2011 Mar; 25(3):739-47. PubMed ID: 21174058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The liver-specific microRNA miR-122: biology and therapeutic potential.
    Filipowicz W; Grosshans H
    Prog Drug Res; 2011; 67():221-38. PubMed ID: 21141732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms.
    Felicetti F; Errico MC; Bottero L; Segnalini P; Stoppacciaro A; Biffoni M; Felli N; Mattia G; Petrini M; Colombo MP; Peschle C; Carè A
    Cancer Res; 2008 Apr; 68(8):2745-54. PubMed ID: 18417445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas.
    Corsten MF; Miranda R; Kasmieh R; Krichevsky AM; Weissleder R; Shah K
    Cancer Res; 2007 Oct; 67(19):8994-9000. PubMed ID: 17908999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth.
    Streicher KL; Zhu W; Lehmann KP; Georgantas RW; Morehouse CA; Brohawn P; Carrasco RA; Xiao Z; Tice DA; Higgs BW; Richman L; Jallal B; Ranade K; Yao Y
    Oncogene; 2012 Mar; 31(12):1558-70. PubMed ID: 21860416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model.
    Callegari E; Elamin BK; Giannone F; Milazzo M; Altavilla G; Fornari F; Giacomelli L; D'Abundo L; Ferracin M; Bassi C; Zagatti B; Corrà F; Miotto E; Lupini L; Bolondi L; Gramantieri L; Croce CM; Sabbioni S; Negrini M
    Hepatology; 2012 Sep; 56(3):1025-33. PubMed ID: 22473819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancers.
    Imam JS; Buddavarapu K; Lee-Chang JS; Ganapathy S; Camosy C; Chen Y; Rao MK
    Oncogene; 2010 Sep; 29(35):4971-9. PubMed ID: 20603620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA regulation of oncolytic herpes simplex virus-1 for selective killing of prostate cancer cells.
    Lee CY; Rennie PS; Jia WW
    Clin Cancer Res; 2009 Aug; 15(16):5126-35. PubMed ID: 19671871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of microRNA-29 by antisense inhibitors and a PPAR-gamma agonist protects against myocardial ischaemia-reperfusion injury.
    Ye Y; Hu Z; Lin Y; Zhang C; Perez-Polo JR
    Cardiovasc Res; 2010 Aug; 87(3):535-44. PubMed ID: 20164119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Establishment of a highly-metastatic model of human primary melanoma of the small intestine orthotopically transplanted in the small intestine of nude mice].
    Tuo CW; Zhang N; Liu QZ; Yang B; Wang MY
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):885-90. PubMed ID: 19173986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin.
    Leonetti C; Biroccio A; Candiloro A; Citro G; Fornari C; Mottolese M; Del Bufalo D; Zupi G
    Clin Cancer Res; 1999 Sep; 5(9):2588-95. PubMed ID: 10499637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA silencing in primates: towards development of novel therapeutics.
    Petri A; Lindow M; Kauppinen S
    Cancer Res; 2009 Jan; 69(2):393-5. PubMed ID: 19147547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.